Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1994/011155external-prioritypatent/WO1995010278A1/en
Application filed by Hoechst Marion Roussel IncfiledCriticalHoechst Marion Roussel Inc
Publication of NO961496D0publicationCriticalpatent/NO961496D0/no
Publication of NO961496LpublicationCriticalpatent/NO961496L/no
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Hydrogenated Pyridines
(AREA)
Abstract
Foreliggende oppfinnelse an- går en metode for behandling av en pasient som lider av en allergisk syk- dom, omfattende daglig administrering til angitte pasient av en mengde av terfenadinkarboksylat på fra ca. 10 mg til ca. 50 mg.
NO961496A1993-10-151996-04-15Behandling av allergiske sykdommer med terfenadinkarboksylat
NO961496L
(no)
Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
WS7622A enthaltende prophylaktische/therapeutische Zusammensetzung zur Vorbeugung und Behandlung von verstreuter, intravaskulärer Koagulation, chronischer, infektiöser Atemwegskrankheiten oder chronischer Bronchitis